Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
PDS Biotechnology (NASDAQ:PDSB) announced the publication of interim Stage 1, Phase 2 clinical data for its lead antibody-drug conjugate (ADC) candidate, PDS01ADC, in JCO Oncology Advances on April 15, 2026.
Telix Pharmaceuticals (NASDAQ:TLX) has reached a critical clinical milestone with the dosing of the first patient in its pivotal Phase 3 IPAX BrIGHT trial.
eToro (NASDAQ:ETOR) announced on Wednesday, April 15, 2026, that it has entered into a definitive agreement to acquire Zengo, a leading provider of self-custodial crypto wallets.
Omnia Metals (ASX:OM1) announced a multi-faceted strategic expansion into the United States' critical minerals sector.
FDA granted Immutep (ASX:IMM) Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma.
The Australian Communications and Media Authority has slapped non-bank lender Latitude Group (ASX:LFS) with a $4 million fine.
Accelerate Resources (ASX:AX8) commenced aircore drilling at its high-priority Fluffy prospect.
The Duratec Ertech joint venture has been awarded a $281 million contract by the Department of Defence.
Winmark (NASDAQ:WINA), known as "the Resale Company®," announced its financial results for the first quarter ended March 28, 2026.
60 Degrees Pharmaceuticals (NASDAQ:SXTP) announced on April 15, 2026, a strategic partnership with Runway Health to make ARAKODA (tafenoquine) available to U.S. travelers via a dedicated telehealth platform.
